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ABSTRACT 
Malnutrition is caused by inadequate protein intake and affects growth factor. High protein from patin (Pangasius 
hypophthalmus) fish is a well-known protein source. This study aims to investigate the effect of patin fish protein concentrate 
(PFPC) in the IGF-1 and IGFBP-3 level of Sprague Dawley (SD) neonate rats-induced malnutrition. Thirty male SD neonate 
rats were divided randomly into five groups, namely normal control (K1), malnutrition control (K2), malnutrition with PFPC 
13.26 mg.g-1 body weight (BW)/day (X1), malnutrition with PFPC 19.89 mg.g-1 BW/d (X2), and malnutrition with casein 
supplement 13.26 mg.g-1 BW/d (X3). K1 received a standard diet, while the others received a low 8% protein diet (L8PD) 
since those were born until 21 days. The standard diet was refed for all groups during the intervention (14 days). IGF-1 and 
IGFBP-3 levels were measured by ELISA. Normal data were analyzed by using One-way ANOVA which then was followed 
by post-hoc Bonferroni. Meanwhile, the others were analyzed by Kruskal Wallis and followed by Mann-Whitney U-test. 
Spearman test was used for correlation. PFPC contained 81.07% of protein, 4.08% of fat, 7.24% of moisture, 2.77% of ash, 
and 4.83% of carbohydrate. These contents had affected the growth factor. As a result, in the PFPC intervention, IGF-1, and 
IGFBP-3 levels (p <0.05) were decreased, while the controls were increased. The decreased values were shown in IGFBP-3 
levels (p <0.05) while the increase was shown in both controls. On the other hand, the increase in body weight was shown in 
all groups, including control ones. A strong correlation was found between IGF-1 and IGFBP-3. PFPC has additional value 
on repairing malnutrition that is the best dose in effecting IGF-1 dan IGFBP3 levels is 13.26 mg.g-1 BW/d. 
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INTRODUCTION 
 Malnutrition is generally caused by restricted dietary 
intakes and ended with poor linear growth even in early life 
(Kartini, 2019; Aheto, 2015). Globally, undernutrition 
conditions have been caused by the mortality of 30% of 
children (Blossner and De Onis, 2005). The prevalence is 
still high in some developing countries in South East Asia 
such as Indonesia (UNICEF, WHO, and World Bank 
Group, 2018).  
 Malnutrition is caused by a lack of nutrients intake, such 
as a protein restriction diet (Kartini, 2019; Saunders, 
2011; Gibson, 2005). Malnutrition, especially in the golden 
age, can cause growth faltering, such as stunting. Besides is 
also has a reciprocal relationship with infections that lead to 
systemic inflammation (Bartz, 2014; Guerrant, 2008; 
Lunn, 2007). Consequently, this condition results in the 
disruption of the body's hormonal function, including 
disruption of growth hormone (GH). Furthermore, the 
disruption also affects the role of GH in releasing growth-
related substances in the hypothalamus-pituitary-GH axis 
interaction. Malnutrition will also affect the mechanism in 
producing IGF-1 and IGFBP-3, the binding protein which 
is the principle binding protein of IGF-1 (Deboer, 2017; 
Bartz, 2014). 
 IGF-1 and IGFBP-3 are produced in the liver. They have 
a function in mediating the protein metabolism and 
controlling the growth factors which are accumulated in 
somatic cells (Guntur and Rosen, 2013; Skottner, 2012; 
McDonald, 2007; Laron, 2001). Their production is a form 
of GH secretion and even shows a resistant condition 
(Misra, 2003; Hintz, 1978). Decreased IGF-1 values are 
shown in acute malnutrition, while IGFBP-3 in chronic one. 
Both of them have special functions in several metabolic 
conditions (Gupta, 2011; Hoppe, 2004). Several studies on 
subjects with severe acute malnutrition, even normal, 
showed a decrease (Kartini, 2019; Hoppe, 2004; Misra, 
Potravinarstvo Slovak Journal of Food Sciences 
Volume 14 1067  2020 
2003). Consuming high protein intake can improve this 
condition especially the function of IGF-1 and IGFBP-3. 
 Fish protein concentrate is a product resulting from the 
relieving moisture and fat content. Bioactive compounds 
and peptide contained in fish have benefits to control 
growth (Kundam, 2018). Patin (Pangasius 
hypophthalmus), a freshwater fish, is a tropical fish that can 
live in many countries in Southeast Asia such as Indonesia. 
Many fisheries technologies can maintain and protect the 
fish protein from damaged, such as by making fish protein 
concentrate. The fish protein intervention studies are well-
known studies and affect many pre-clinical and clinical 
indications (Nobile, 2016). With 80% protein reaches of 
PFPC and has greater digestibility, amino acids from patin 
fish, especially lysine and leucine, are more absorbed by the 
body than other protein sources, such as meat and poultry 
protein (Pratama, 2018). Discussing the high protein study 
and its effect on linear growth and malnutrition, high protein 
intake has shown its effects in increasing IGF-1 in boys and 
increasing IGFBP-3 of premature infants (Hoppe, 2004; 
Smith, 1997). This study aims to investigate whether the 
intervention of patin fish protein concentrate affects the 
IGF-1 and IGFBP-3 levels of Sprague Dawley (SD) neonate 
rats-induced malnutrition. 
  
Scientific hypothesis  
 There are various doses of patin fish protein concentrate 
that affect insulin-like growth factor (IGF)-1 and IGF 
binding protein (IGFBP)-3 levels of Sprague Dawley 
neonate rats-induced malnutrition. 
 
MATERIAL AND METHODOLOGY 
Preparation of patin fish protein concentrate  
 Patin fish were bought at fishpond in the Ambarawa sub-
district, Semarang Regency, Central Java Province, 
Indonesia. The selected patin fish as those that have a good 
condition as shown by fresh patin that has just been 
captured, weighs about 1 kilogram for one fish, has fresh 
flesh, has gills that are still red, the color does not change 
and odorless. Then the patin fish were filleted and cleaned. 
The filleted fish were ground using a food processor with 
the addition of salt (0.5%) and NaHCO3 (1.5%). Next, fish 
pasta was steamed for 30 minutes. The steamed pasta was 
then pressed and extracted by 96% food-grade ethanol with 
a 3:1 patin ratio. The extraction was carried out twice to 
fully relieve the moisture and fat content. The extracted fish 
was then dried at a temperature of 40 oC and mixed until 
refined size (60 mesh). The PFPC was wrapped in food-
grade silica gel and stored in the bottle at 4 °C (AOAC 
International, 2006).    
 
Proximate analysis of patin fish protein 
concentrate 
 The proximate analysis includes moisture, protein, ash, 
fat, and carbohydrate content (by difference) (AOAC, 
2005). 
 
Research design and experimental-animals  
 This research was a true-experiment study with a 
randomized pre-post test and has a control group design. 
The animal used was male Sprague Dawley rats, aged 21 
days induced with a low 8% protein diet (L8PD), except 
health control. The acclimatization was held in the 
laboratory of Gadjah Mada University, Yogyakarta. The 
rats were placed in each group and numbered. They were 
placed at a regulated temperature (21oC) and a clean cage. 
They were given ad-libitum water during the experiment. 
Animal care in the laboratory was carried out in accordance 
with the animal Laboratory Guideline from the Central 
Laboratory for Food and Nutrition Studies, Gadjah Mada 
University, Yogyakarta. 
 Thirty rats were divided into five groups, namely groups 
of normal control (K1), malnutrition control (K2), 
malnutrition with PFPC 13.26 mg.g-1 BW/day (X1), 
malnutrition with PFPC 19.89 mg.g-1 BW/d (X2), and 
malnutrition with casein supplement 13.26 mg.g-1 BW/d 
(X3) (Wong, 2019). The malnutrition-condition was 
induced since 0 - 21 days old of neonate rat or through 
maternal L8PD (Table 1). After 3 days of acclimatization, 
the IGF-1 and IGFBP-3 were examined before the 
intervention. The intervention group was treated with the 
CMC-Na suspension method for 14 days. Body weight was 
measured every week since the animals were born until the 
interventions were ended. All of the groups were fed with 
Comfeed II standard-diet (CSD) during the intervention 
period. The blood sample was taken again at the end of the 
intervention through the retroorbital plexus. Blood samples 
were collected in a centrifugation tube and centrifuged 4000 
rpm in 15 minutes. IGF-1 and IGFBP-3 levels were 
analyzed by ELISA (Kartini, 2019; Alishahi, 2013).  
 
 
Table 1 Ingredient compositions (g/kg) of low 8% 
protein diet (L8PD) fed to malnutritiomn-induced rats. 
Ingredients L8PD (g)* 
Casein purified high nitrogen 
Corn starch  
Cottonseed Oil 















 Figure 1 Patin Fish Protein Consentrate. 
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Statistical analysis   
 Results were expressed as mean ± SD (for normally 
distributed data), otherwise, it was expressed as median 
(min-max). Statistical difference was analyzed by using a 
one-way analysis of variance (ANOVA) followed by post 
hoc Bonferroni for normally distributed data, otherwise, the 
Kruskal-Wallis test followed by Mann-Whitney-U-test was 
used. The software used was SPSS software version 22 
(SPSS Inc, Chicago, IL, USA). Spearman’s correlative test 
was used to analyze the relationship between variables. 
Statistical analyses were done by the computer. The 
differences and correlations were considered significant at 
p-value <0.05 and 95 % confidence intervals. The strength 
of the correlation was determined by the r-value.   
 
RESULTS AND DISCUSSION 
 Related data about PFPC was shown as proximate analysis 
(Table 2). The other data about intervention processed was 
obtained from 30 Sprague Dawley-neonate rats, which were 
divided into each group consisting of 6 neonatal rats. The 
experimental animals used before intervention had an 
average body weight of 76.58 grams for the malnutrition 
group and 106.5 grams for the healthy control (data not 
shown).  
 Wilcoxon test carried out on the body weight before and 
after the intervention, showed that the intervention of PFPC 
increased the body weight in the all-treatment-group as 
shown in Table 3 and Table 4. Healthy-control-K1-group 
has experienced a significant increase in BW (p = 0.026). 
Statistically, the difference was also found on the pre-post 
intervention change (∆) of neonate rats-BW among all 
groups (Kruskal Wallis test; p = 0.001). Meanwhile Mann-
Whitney U- test was also performed on two groups. The ∆-
neonate rats-BW of all-intervention-malnutrition-group 
were higher than malnutrition-control-K2-group and this 
result was significant (X1 and X2 had the same p-value;  
p = 0.004). The ∆-neonate rats-BW of the X1-group was not 
different from the X3-group (p = 0.868). This finding 
demonstrated that PFPC can increase body weight which is 
higher in malnutrition neonate rats. Besides, this finding 
also showed that the ability of PFPC in dose 13.26 mg.g-1 
BW/d in increasing body weight of malnutrition neonate 
rats has the same ability obtained from the casein 
supplement. The difference in body weight obtained during 
the study was shown in Figure 1.  
 The IGF-1 levels decrease at the end of the intervention, 
and significantly different (p = 0.028 for X1 and X2,  
p = 0.027 for X3; Table 4), while K2-group experienced a 
significant increase IGF-1 level (p = 0.027). The pre-post-
intervention-change (∆) of IGF-1 levels was significantly 
different among five-groups (Kruskal Wallis test; p = 
0.001). Meanwhile, the ∆-IGF-1-levels of all-intervention-
malnutrition-group were different compared to 
malnutrition-control-K2-group (X1, X2, and X3 had the 
same p-value; Mann-Whitney U-test, p = 0.004). But, in 
suppressing of IGF-1 between all-malnutrition-treated-
group, statistical analysis showed that the ∆ IGF-1 in X1-
group was not different from X2 (p = 0.055) and X3-group 
(p = 0.054). This finding indicated that the ability of PFPC 
in dose 13.26 mg.g-1 BW/d was not different from the PFPC 
in dose 19.89 mg.g-1 BW/d and the given of casein 




 Figure 1 Changes of body weight of neonate rats during the study. Malnutrition was induced from day 0 to 21st  
by giving low 8% protein diet (L8PD). PFPC intervention was started from day 24th to 38th. Three days 
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 The IGFBP-3 levels experienced a decrease after the 
performance of the intervention. The levels were 
significantly different (X1, X2 and X3 had the same  
p-value; p = 0.001; Table 4), while K2-group experienced 
a significant increase of IGFBP-3 level (p = 0.034). The pre-
post intervention-change (∆) of the IGFBP-3 level was 
significantly different among the five groups (One-way 
ANOVA test; p = 0.001). The ∆-IGFBP-3-levels of all-
intervention-malnutrition-group were different compared to 
malnutrition-control-K2-group (X1, X2, and X3 had the 
same p-value; Post Hoc Bonferroni test, p = 0.001). 
 The Spearman test on all data from all rats at the end of 
the study showed there was a very strong correlation that 
was found between the variables (IGF-1 and IGFBP-3). A 
very strong positive correlation was observed between IGF-
1 and IGFBP-3 (r=0.861). This correlation was less weak 
before PFPC intervention began (data not shown). 
 Malnutrition can be ended with a linear growth disruption. 
Restriction of protein intake during the lactation period 
affects the disruption of long term linear growth (Cherala, 
2006; Zambrano, 2005). We examined that the decreasing 
value of IGF-1 levels in the malnutrition-treatment-group 
after the intervention was caused by an inflammatory 
response. Systemic inflammation which occurs due to 
protein restriction during early life has not been repaired by 
early re-feeding.  
 Inflammation is a possible indication in the intervention 
group which is shown through the decreasing serum IGF-1 
levels in neonatal rats. Indications of inflammation are 
thought to occur due to the placement of each group of 
neonate rats in one cage. The same result was also found in 
other previous studies showing the effect of interleukin 6 
(IL-6) inflammatory biomarkers on IGF-1 descent. The 
decrease of IGF-1 is related to the mitogenic function of 
IGF-1 thereby inducing a decrease of its concentration in 
cell proliferation (Chen, 2009; Lann and LeRoith, 2008; 
Jenkins, 2000).  
 These indications of inflammation due to chronic 
malnutrition are also associated with GH resistance 
response, which modulates gluconeogenesis (Hawkes and 
Grimberg, 2015; Fazeli and Klibanski, 2014; Difedele, 
2005; Turner, 1976). This condition can be attributed to the 
increase of GH and growth hormone receptor (GHr) which 
modulates glucose homeostasis as indicated by an increase 
in body weight. However, in the mechanism of the 
endocrine system, the GH resistance condition causes a 
decrease in IGF-1 and IGFBP-3 concentrations (Martins, 
2017; Liu, 2004; Hefferman, 2001).  
Table 2 Proximate analysis of PFPC. 











Note: * L8PD for K2,X1,X2, and X3. 
 
 
Table 3 Statistical analysis of body weigth, IGF-1 and IGFBP-3 (control groups). 
Variables K1 K2 
Pre Post pa ∆ Pre Post pa ∆ 
BW 106.5  
(104 - 112) 
152.5  
(149 - 158) 
0.026 48  
(38 - 53) 
75.50  
(70 - 81) 
98.5  
(92 - 101) 
0.026 22.00  
(20.00 - 23,00) 
IGF-1 41.32  
(39.77 - 42.53) 
42.35  
(40.81 - 43.22) 
0.026 1.03  
(0.69 - 1.38) 
69.04  
(67.67 - 71.11) 
70.59  
(68.70 - 72.14) 
0.027 1.20  
(0.69 - 1.72) 
IGFBP-3 40.89 ±2.69 42.07 ±2.43 0.004 1.17 ±0.57 92.16 ±1.96 94.53 ±2.23 0.034 2.37 ±1.99 




Table 4 Statistical analysis of body weigth, IGF-1 and IGFBP-3 (group with PFPC and casein intervention). 
Variables P1 P2 P3 pb pc pd 
Pre Post pa ∆ Pre Post pa ∆ Pre Post pa ∆    
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0.001 0.001 0.001 
Note: ap-values were obtained by Wilcoxon test (for BW and IGF-1), paired t test (for IGFBP-3); between pre-post 
intervention. bp-values were obtained by Kruskal Wallis test (for BW and IGF-1), One-way ANOVA test (for IGFBP-
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 Other previous studies have assessed that serum IGF-1 
levels can be assessed at four weeks of intervention. 
Meanwhile, this study assessed the IGF-1 in two weeks’ 
intervention. This is also supported by the insignificant 
assessment of protein synthesis which ended with a 
disruption of metabolism especially the disruption of IGF-1 
synthesis (Caregaro, 2001). The disruption of synthesis of 
the pituitary-GH-IGF1 axis is a major factor in the decrease 
of serum IGF-1 levels after re-feeding. The chronic 
malnutrition intake which has experienced by the subject 
suppresses the key components of IGF-1 and indicates 
impaired its production in the liver (Zamboni, 1996). This 
condition will provide IGF-1 negative feedback to the 
hypothalamus which results in an in increasing GH release. 
The decrease of IGF-1 in this study can also be related to 
the physiological response of IGF-1 which uses amino acids 
together with its pro-insulin structure, despite the subjects 
has been re-feed with high protein intake (Bonefeld and 
Moller, 2011). The other inhibitor that can be related to 
IGF-1 activity is adjusted with the IGFBP sub-type on an 
individual subject and the protease of the binding protein 
which is modulated by the level of their affinity 
(Kamycheva, 2012; Ferry, 1999). 
 Decreasing serum IGFBP-3 levels can cause disrupt IGF-
1 modulation. IGFBP-3 is the principal binding protein that 
modulates the action of IGF-1 as a growth factor. 
Disturbances that are caused by protein restriction and are 
not properly repaired realized that the pituitary-GH-IGF 
axis binding protein has a reciprocal effect (Bang, 1994). 
However, in this study, we found a negative relationship 
where there was a decrease in IGFBP-3 levels after the 
intervention. Previous studies that showed a decrease in 
IGFBP-3 proteolysis activity can make the binding protein 
of IGF-1 as a trigger of low levels of IGF-1 targets. The 
potential of IGFBP-3 in proteolysis depends on its post-
translational modification which has a great impact on IGF-
1 (Rosen and Yakar, 2020). Interestingly, the proteolysis 
mechanism of IGFBP-3 can occur with unknown protein in 
the extracellular matrix besides IGF-1. This condition 
exactly affects the decreasing IGF-1 level (Vorwerk, 1998; 
Bereket, 1995; Bang, 1994).  
 Proteolysis is the most possible mechanism in this study 
which has a function to reduce serum IGFBP-3 levels. Both 
levels of  IGF-1 and IGFBP-3 which were decreased show 
that the mechanism most likely caused by proteolysis 
(Dauncey, 1993). Interventions in malnutrition children by 
re-feeding show a decrease in proteolytic activity, but 
restoring energy intake in the subjects (Zamboni, 1996). 
Decreasing the potency of proteolysis contributes to 
reducing the ability of IGFBP-3 to bind with IGF-1. The 
other reason is other competitors that can bind with IGF-1, 
such as IGF-1 receptors. These statements are related to 
IGFBP-3 which regulates IGF-1 bioactivity through non-
specific proteases (Pucilowska, 1993; Davenport, 1992). 
The action capability of this specific IGFBP-3 can even 
limit the bioavailability of free IGF-1 which is further 
regulated in the extracellular space if it is proteolysis must 
be done (Rosen and Yakar, 2020). This research proved 
that IGF-1 can be modulated by one of its main binding 
proteins (IGFBP-3), which is supported by acid-labile sub-
unit to make a binary complex. 
 Interestingly, other growth factors besides IGF-1 and 
IGFPB-3 might be involved and affected the increasing 
body weight of neonate rats. These growth factors show the 
effect of suppression on IGF-1 and IGFBP-3 but support the 
mechanism of other growth biomarkers which is associated 
with the increasing body weight (Bereket, 1995; Bang, 
1994). Excess of GH secretion, as the impact of its 
resistance condition, is stimulated by excess exactly of GHr 
secretion to support GH function. However, this condition 
reflects complete negative feedback as the result of 
decreasing in IGF-1 levels (Liu, 2004; Zamboni, 1996). 
The effect of increased GHr showed in previous studies 
modulates the increase in somatic growth (Liu, 2004; 
Hefferman, 2001). This hypothesis supports the results of 
this study. Deleting of GHr gene will affect decreasing body 
size (Liu, 2004). In this study, malnutrition neonate rats 
which were re-feed with supplementation of PFPC showed 
a significant growth acceleration compared to the healthy 
control. 
 Malnutrition condition, which was caused by cachexia 
symptoms and inflicted from malignancy response, also 
observed a similar indication. It was shown significantly by 
a specific combination of high-protein intake intervention 
which contained leucine (Van Norren, 2009). Increasing 
body weight is a positive effect from consuming high-
protein intake which modulates the anabolism process in 
many cells and tissues is targeted by protein synthesis and 
the contribution of amino acids (Rogers and Harper, 
1965).  
 The findings in protein intervention also improve clinical 
symptoms due to protein restriction. Other growth factors 
can affect the increase in body weight of malnutrition with 
re-feeding (Soliman, 1986). Increasing body weight can be 
driven by the anabolic response that is controlled by GH. 
The increase of GH secretion provides an alternative source 
of metabolism through fat mobilization and hepatic glucose 
production. This response has been reported in subjects 
without insulin resistance in basal conditions (Smith, 
1981).  
 The increase of body weight which is indicated by 
increased GH is also associated with carbohydrate and fat 
homeostasis (Liu, 2004). Other studies conducted in 
children with marasmic and kwashiorkor showed lower 
serum IGF-1 levels in the marasmic group. This shows that 
energy intake takes the main place to process rather than the 
food protein process (Underwood, 1994; Dauncey, 1990). 
Another study also observed re-feeding carried out by 
returning the intake of rats to the standard diet could allow 
that the high intake of protein would not necessarily be 
effectively metabolized.   
 Furthermore, amino acid, especially lysine and leucine 
which are high in PFPC products could also change weight 
gain. We found in this study that the PFPC contained 
protein amounting 80% (Table 2) and the PFPC in a dose 
of 13.26 mg.g-1 BW/d did not have different effects from 
casein supplement in the same dose. These findings indicate 
that the ability of PFPC is no different from casein, which 
has purified high protein. It is expected that the PFPC has 
certain amino acids for gaining weight. Other studies also 
recognize that oral leucine supplementation stimulates 
muscle protein synthesis and is not dependent on insulin 
(Dardevet, 2002; Anthony, 2000). Once again, those 
findings supported this study that the mechanism of 
decreasing IGF-1 does not affect the increase of body 
weight because of its function associated with amino acids 
Potravinarstvo Slovak Journal of Food Sciences 
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and pro-insulin (Bonefeld and Moller, 2011; 
Rinderknecht and Humbel, 1978). Although the protein 
concentration in this study product was high, even 
exceeding the concentration of similar products from the 
sThe isoleucine contin PFPC is higher than white fish 
protein hydrolysate (Windsor and Barlow, 1981).  But, we 
did not further examine the amino acid content and their 
digestibility through in vitro studies. 
 The high protein concentration also supports the lipid and 
carbohydrate pool of neonate rats. Increased protein intake 
can affect the amount of lipids and carbohydrates stored in 
adipose tissue, especially white adipose tissue (WAT) 
(Zhang, 2019). As the largest cholesterol provider, WAT 
can be involved in cholesterol metabolism where 
cholesterol can increase to high-density lipoprotein (HDL) 
(Zhang, 2010). Besides WAT is also involved in the 
endocrine system which secretes protein factors, such as 
adipokines associated with energy regulation and 
inflammatory homeostasis (Rafols, 2014; Khovidhunkit, 
2004). From the results of this study and existing theories, 
they indicate that protein intake and high-fat content of 
PFPC products affect the function of the adiposity system 
and lipoprotein. This mechanism puts an end to weight gain 
even though there is an indication of inflammation that is 
shown from the decrease in IGF-1 and IGFBP-3 levels. 
 Limitations of this study we do not examine other growth 
indicators on this intervention except the body weight. 
Discussing another growth factor, we also do not examine 
another related growth factor that can relate to and support 
the hypothesis of this study. Inflammation is not measured 
in this study, as expected to exist in chronic malnutrition 
neonate rats. The proteolytic, which can be the most 
possible involved mechanism in this study is also not 
concerned. We did not concern about the digestible amino 
acid of PFPC which can be compared to other products in 
case of body weight gain of malnutrition rats. Other 




 The administration of patin fish protein concentrate with 
various doses tested, significantly increased the body 
weight, but decreased IGF-1 and IGFBP-3 serum level of 
malnutrition-induced neonatal rats. The administration of 
patin fish protein concentrate with dose 13,26 mg.g-1 body 
weight per day is the most effective dose in increasing body 
weight of malnutrition-induced neonatal rats.  
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